peptide · also known as Bremelanotide

PT-141

Bremelanotide, a cyclic melanocortin-4 receptor agonist.

PT-141 · 10 mg · Lyophilised vial

peptide · also known as Bremelanotide

PT-141

Bremelanotide, a cyclic melanocortin-4 receptor agonist.

€ 35.00per vial, EUR

In stock

Presentation1 option

10 mg · Lyophilised vial€ 35.00

Lyophilised powder in a sealed glass vial

Storage: -20 °C for long-term storage; 2 to 8 °C for under three months; away from light

Tracked shipping EUR 9.95 per order. Benelux 1 to 2 business days, Germany and France 2 to 3, rest of Europe 3 to 5. Details

Batch certificate: not yet published online. Request one for this presentation.

Research use only. Not for human or veterinary use.

What it is

PT-141 (bremelanotide) is a cyclic heptapeptide derived from Melanotan II, acting mainly on the melanocortin-4 receptor. It has been studied in clinical trials and is supplied here as a research reagent.

Where it has been studied

Melanocortin-4 receptor pharmacology
Central nervous system models of sexual behaviour in rodents
Energy balance studies

Selected literature

PT-141 PalatinHedlund P et al. · Curr Opin Investig Drugs, 2004 · PMID 15134289
Prespecified and Integrated Subgroup Analyses from the RECONNECT Phase 3 Studies of BremelanotideSimon JA et al. · J Womens Health (Larchmt), 2022 · PMID 35230162

PubMed records selected for relevance to the compound. They describe published research, not outcomes or uses.

Specifications

Compound	PT-141 (Bremelanotide)
Type	Peptide
Selected presentation	10 mg · Lyophilised vial
Form	Lyophilised powder in a sealed glass vial
Fill volume and concentration	Not applicable (lyophilised)
Label	CELVIVE wordmark, compound name, amount, "Purity: >99%", "For research use only"
Storage	-20 °C for long-term storage; 2 to 8 °C for under three months; away from light
Certificate of analysis	Not yet published online. Request for a batch
Research areas	Hormonal & reproductive
All presentations	10 mg lyophilised vial · € 35.00

Handling

Lyophilised peptides tolerate room temperature for several weeks in transit. Move to cold storage on receipt.
Reconstituted vials are typically used within three to four weeks at 2 to 8 °C; stability varies by compound.
Opened or unsealed vials cannot be returned. Transit damage must be documented within 24 hours.

Storage and stability FAQ